Stay updated on Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial
Sign up to get notified when there's something new on the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page.

Latest updates to the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page
- Check3 days agoChange DetectedLocations sections were expanded to include numerous regional site lists across multiple countries and states. Several existing location blocks were removed.SummaryDifference0.9%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a note that PubMed-pulled publications are automatically filled and may not relate to the study, and updated the page revision to v3.3.2 (replacing the previous v3.2.0 wording).SummaryDifference0.0%

- Check40 days agoChange DetectedA government funding status notice was removed from the page. This does not affect the study’s design, eligibility criteria, or results information.SummaryDifference0.1%

- Check54 days agoChange DetectedThe new screenshot shows the same Study Details page as the old one, with no changes to essential content beyond minor formatting. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a government operations notice with current status and a new software version tag (v3.2.0); removed the previous version tag (v3.1.0).SummaryDifference1%

- Check90 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.0%

Stay in the know with updates to Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page.